Get the Stockscreener App
2.01
8.64%
-0.19
Pre-market:
2.01
Salarius Pharmaceuticals Inc Stock (SLRX) Latest News
Salarius resumes trial for MDS and CMML treatment - Investing.com India
Salarius resumes trial for MDS and CMML treatment By Investing.com - Investing.com Australia
Salarius Pharmaceuticals Announces Patient Enrollment to - GlobeNewswire
Breakthrough Cancer Treatment Shows Triple Survival Time: Trial Back on Track - StockTitan
Deal Dispatch: Biden Punts TikTok Ban To Trump, Plus Another Legacy Retailer Goes Bankrupt - Benzinga
Deal Watch: Bausch Companies Set Hectic Pace At J.P. Morgan With Five Deals - News & Insights
Salarius Pharmaceuticals and Decoy Therapeutics announce merger - MSN
Stock market news: Phio Pharmaceuticals -50.61%, Salarius Pharmaceuticals -28.61% among biggest losers during mid day trading - Business Upturn
Stock market today: Phio Pharmaceuticals -41.48%, Aehr Test Systems -26.86% among biggest losers in early trading - Business Upturn
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Shareholder Alert: Ademi LLP investigates whether Salarius Pharmaceuticals, Inc. is obtaining a Fair Price for its Public Shareholders - Business Wire
Premier of separatist Moldova region says gas cutoff shattered foreign trade - Yahoo! Voices
Biologics Contract Development And Manufacturing Organization (CDMO) Market size to increase by USD 16.32 Billion between 2024 to 2029, Market Segmentation by Type, Product Type, Geography , Technavio - Yahoo Finance
Here’s Why Chimerix, Inc. (CMRX) Is Skyrocketing - Yahoo Finance
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Here’s Why Cidara Therapeutics, Inc. (CDTX) Is Skyrocketing - Yahoo Finance
Here’s Why Solaris Energy Infrastructure, Inc. (SEI) Is Skyrocketing - Yahoo Finance
Houston's Salarius Pharmaceuticals to merge with Gates Foundation-backed co., focus on Covid-19 treatment - The Business Journals
Biogen Offers to Buy Remaining Stake in Sage Therapeutics - Yahoo Finance
Gold Down Over 1%; Salarius Pharmaceuticals Shares Surge - Benzinga
Cancer-Focused Phio Pharmaceuticals Stock Gains 300% On MondayHere's Why - Yahoo Finance
Thermo Fisher Scientific Inc. (TMO): A Bull Case Theory - Yahoo Finance
Stock market news: Phio Pharmaceuticals +296.88%, Salarius Pharmaceuticals +153.67% among top gainers during mid day trading - Business Upturn
FDA approves Zeiss Medical Technology’s MEL 90 excimer laser - Yahoo! Voices
MercadoLibre, Inc. (MELI): A Bull Case Theory - Yahoo Finance
Stock market news: Shallgo saw rise of 286.81% while Kairos Pharma was up by 176.47% during mid day trading - Business Upturn
Crude Oil Surges 3%; Abercrombie & Fitch Shares Plunge - Benzinga
Illumina and NVIDIA Just Dropped a Genomics Bombshell - Yahoo Finance
Xiaohongshu, China's answer to Instagram, hits no. 1 on the App Store as TikTok faces US shutdown - Yahoo! Voices
Why Madrigal Pharmaceuticals Stock Is Sinking Today - Yahoo! Voices
Gilead and LEO Pharma link on programmes for inflammatory conditions - Yahoo! Voices
US Stocks Mixed; Nasdaq Down Over 1% - Benzinga
Eli Lilly to buy Scorpion Therapeutics' cancer therapy for up to $2.5 billion - Yahoo Finance
Stock market today: Phio Pharmaceuticals +289.93%, Sage Therapeutics +34.95% among the top gainers in early trading - Business Upturn
InboxArmy CEO Scott Cohen Appointed as New Committee Co-Chair for ANA Email Excellence Center - Yahoo Finance
Stock market today: Kairos Pharma saw rise of 130.20% and Salarius Pharmaceuticals was up by 180.52% in early trading - Business Upturn
Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Value Stock - Yahoo Finance
Salarius Pharmaceuticals Merges with Decoy Therapeutics - TipRanks
Salarius Pharmaceuticals to Merge with Decoy Therapeutics - MarketWatch
Salarius Pharmaceuticals and Decoy Therapeutics Announce Definitive Merger Agreement - The Manila Times
Ekso Bionics Reports Certain Preliminary Fourth Quarter 2024 Financial Results - The Manila Times
Salarius, Decoy Therapeutics enter definitive merger agreement - TipRanks
Salarius Pharma Merges with AI Drug Designer Decoy Therapeutics, Plans Pan-Coronavirus Drug - StockTitan
Phio Pharmaceuticals Announces Promising Results of Second Cohort from Its Ongoing Clinical Study of PH-762 - Yahoo Finance
Illumina, Nvidia team to use AI in foundation models - Yahoo Finance
Pre-market Movers: ONCO, EYEN, SGMO, VSTM... - RTTNews
Crinetics Pharmaceuticals Announces January 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
Viking Therapeutics Starts Mid-Stage Study on Oral Weight-Loss Drug - Yahoo Finance
Bexion Pharmaceuticals, Inc. Announces Poster Presentation at ASCO GI 2025 - Yahoo Finance
Axcelis Technologies Inc (NASDAQ:ACLS): Vulnerable to Disruption and Market Downturns - Yahoo Finance
HOTH Stock Soars as Skin Toxicity Study in Cancer Patients Meets Goal - Yahoo Finance
Is FormFactor, Inc. (FORM) the Best Quantum Computing Stocks to Buy for 2025? - Yahoo Finance
Is Applied Therapeutics (APLT) the Best Penny Stock to Invest In According to Media? - Yahoo Finance
HOOKIPA Pharma Announces Notice to Shareholders Regarding U.K. Disclosure Requirements - Yahoo Finance
Akero Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference - Yahoo Finance
Viking Therapeutics, Inc. (VKTX) Stock Sinks As Market Gains: What You Should Know - Yahoo Finance
Ewing Sarcoma Clinical Trials 2024: EMA, PDMA, FDA Approvals, - openPR
Why ACADIA Pharmaceuticals Inc. (ACAD) Is Skyrocketing - Yahoo Finance
Why Is Verve Therapeutics, Inc. (VERV) Among the Top CRISPR Stocks to Invest In? - Yahoo Finance
Salarius Announces Allowance of New European Patent Covering Seclidemstat - Marketscreener.com
Salarius Pharmaceuticals (NASDAQ:SLRX) Trading 1.3% Higher – Time to Buy? - Defense World
Will TG Therapeutics, Inc. (TGTX) Make You Rich In 2025? - Yahoo Finance
Pre-market Movers: PHIO, IKT, CDT, WHLM... - RTTNews
When Will ESSA Pharma Inc. (NASDAQ:EPIX) Turn A Profit? - Yahoo Finance
Why Did Summit Therapeutics Inc. (SMMT) Jump Yesterday? - Yahoo Finance
SLRX stock touches 52-week low at $1.24 amid market challenges By Investing.com - Investing.com South Africa
Zomedica Appoints Scott A. Jordan Executive Vice President, Finance & Chief Financial Officer - Yahoo Finance
SLRX stock touches 52-week low at $1.24 amid market challenges - Investing.com
Salarius Pharmaceuticals, Inc. announced that it expects to receive $10 million in funding - Marketscreener.com
Recent 26% pullback isn't enough to hurt long-term Rigel Pharmaceuticals (NASDAQ:RIGL) shareholders, they're still up 50% over 1 year - Yahoo Finance
0.82%
0.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):